Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : People entities : Novartis ag save search
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: 0.0%
H: 8.64%
C: 8.36%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.15%
H: 0.31%
C: 0.06%
BLBD | $33.6 -1.81% -1.85% 510K
|
Producer Manufacturing
|
| O: 1.02%
H: 1.29%
C: 1.17%
ALVR | $0.74 -2.23% -2.28% 530K
|
Health Technology
|
| O: -1.42%
H: 7.9%
C: 3.52%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 3.05%
H: 5.92%
C: 1.18%
pdufa commercial
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
Published: 2023-10-02 (Crawled : 14:00) - biospace.com/
AADI | $1.81 -0.55% -0.55% 150K
|
Manufacturing
|
| O: 3.1%
H: 0.2%
C: -13.83%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -0.5%
bioscience
Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.13%
H: 0.06%
C: -1.02%
CERS | News | $1.645 0.31% 0.3% 760K
|
Health Technology
|
| O: -1.3%
H: 5.92%
C: 0.66%
corporation
Alimera Appoints Roger Sawhney, M.D. to Its Board of Directors
Published: 2023-02-27 (Crawled : 16:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.64%
H: 0.01%
C: -0.72%
KKR | $93.35 -1.35% -0.38% 4.6M
|
Finance
|
| O: 1.6%
H: 0.75%
C: -0.47%
ALIM | $3.4 -4.23% -4.41% 57K
|
Health Technology
|
| O: 0.22%
H: 1.98%
C: -2.25%
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Published: 2023-01-23 (Crawled : 17:00) - biospace.com/
AZTA | $50.49 -1.33% -1.35% 420K
|
n/a
|
| O: -0.07%
H: 2.8%
C: 2.48%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.29%
H: 0.77%
C: 0.45%
VCYT | $19.23 1.96% 1.92% 810K
|
Health Technology
|
| O: 1.21%
H: 5.44%
C: 4.49%
XGN | $1.4 -4.0% 8.5K
|
Health Services
|
| O: -1.4%
H: 4.26%
C: 0.71%
Seagen Names David R. Epstein as Chief Executive Officer and Director
Published: 2022-11-10 (Crawled : 13:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -1.69%
H: 0.1%
C: -3.37%
Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors
Published: 2022-07-07 (Crawled : 16:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.38%
H: 1.11%
C: 0.89%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.75%
H: 0.23%
C: 0.05%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: -0.19%
H: 1.04%
C: 0.24%
MO 4 | $41.3 0.49% 0.29% 15M
|
Consumer Non-Durables
|
| O: 0.75%
H: 1.24%
C: 0.82%
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: 0.11%
H: 3.05%
C: 0.15%
EYEN | $0.5385 -0.15% -0.15% 570K
|
Health Technology
|
| O: -2.14%
H: 4.92%
C: 4.92%
Third Harmonic Bio Appoints Edward R. Conner, M.D., as Chief Medical Officer
Published: 2022-06-06 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.87%
H: 2.91%
C: 2.91%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: -1.04%
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Published: 2022-03-30 (Crawled : 12:00) - biospace.com/
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: 0.15%
H: 5.83%
C: -4.29%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.58%
H: 0.56%
C: -0.07%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.59%
H: 0.75%
C: 0.27%
management therapeutics growth
Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors
Published: 2022-03-17 (Crawled : 13:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
therapeutics
AavantiBio Announces Formation of Scientific Advisory Board
Published: 2022-02-09 (Crawled : 14:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
IBIO | $1.77 -6.35% -0.57% 180K
|
Health Technology
|
| O: 2.98%
H: 0.0%
C: 0.0%
ces
Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors
Published: 2021-11-19 (Crawled : 15:30) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.83%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.39%
H: 0.36%
C: -0.77%
biopharma
AavantiBio Further Enhances Leadership Team with Appointment of Jenny Marlowe, Ph.D. as Chief Scientific Officer
Published: 2021-11-16 (Crawled : 14:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.05%
H: 0.14%
C: -0.82%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
IBIO | $1.77 -6.35% -0.57% 180K
|
Health Technology
|
| O: -6.01%
H: 0.0%
C: 0.0%
Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.2%
H: 0.96%
C: 0.38%
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: -0.15%
H: 4.32%
C: 2.53%
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.0%
H: 2.44%
C: -0.15%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 0.6%
H: 2.39%
C: -0.48%
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 0.8%
H: 2.63%
C: -1.58%
Excision BioTherapeutics Expands Management Team with Three Key Appointments
Published: 2021-10-12 (Crawled : 13:15) - biospace.com/
SYK | $327.45 -2.55% 0.0% 2.1M
|
Health Technology
|
| O: 0.47%
H: 0.13%
C: -0.68%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.11%
H: 0.34%
C: -0.33%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -1.44%
RCKT M | $23.44 -1.01% -1.02% 550K
|
Health Technology
|
| O: 1.3%
H: 0.9%
C: 0.31%
CLLS | $2.48 0.81% 0.4% 15K
|
Health Technology
|
| O: 1.33%
H: 2.18%
C: 0.0%
iot
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 1.42%
H: 2.38%
C: 1.96%
BioSpace Movers & Shakers, May 21
Published: 2021-05-21 (Crawled : 15:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.24%
C: 0.0%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: 0.52%
H: 1.19%
C: -0.07%
XERS | $1.77 -0.56% -0.56% 1.1M
|
Health Technology
|
| O: 1.71%
H: 0.61%
C: -2.53%
TELA | $5.15 -0.39% -0.39% 95K
|
Health Technology
|
| O: 1.36%
H: 4.17%
C: -1.41%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -0.46%
IART | News | $31.63 -0.97% -0.98% 510K
|
Health Technology
|
| O: -0.32%
H: 1.67%
C: -0.61%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.98%
H: 2.74%
C: 1.71%
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 0.77%
H: 3.05%
C: 0.38%
space spac
Fore Biotherapeutics Strengthens Leadership Team with Executive and Board Appointments
Published: 2021-05-19 (Crawled : 14:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.21%
H: 0.4%
C: 0.03%
XERS | $1.77 -0.56% -0.56% 1.1M
|
Health Technology
|
| O: -2.23%
H: 1.99%
C: -0.57%
TELA | $5.15 -0.39% -0.39% 95K
|
Health Technology
|
| O: -0.22%
H: 1.49%
C: -1.12%
IART | News | $31.63 -0.97% -0.98% 510K
|
Health Technology
|
| O: -1.24%
H: 1.5%
C: 1.15%
iot
Oragenics Issues Letter to Shareholders
Published: 2021-05-18 (Crawled : 13:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.1%
H: 0.41%
C: 0.07%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.24%
H: 0.81%
C: 0.28%
Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 0.35%
H: 0.4%
C: -2.18%
ceo leo
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.